IT/QA and Regulatory Aspects of Digital Pathology: Results of the 8th ESTP International Workshop

Author:

Boisclair Julie1ORCID,Bawa Bhupinder2ORCID,Barale-Thomas Erio3ORCID,Bertrand Lise4,Carter Jonathan5,Crossland Richard5ORCID,Dorn Celine1,Forest Thomas6ORCID,Grote Sabine7ORCID,Gilis Anja3ORCID,Hildebrand Deon8,Knight Brian9ORCID,Laurent Sébastien10,Marxfeld Heike Antje11ORCID,Østergaard Steen Jørgen12ORCID,Roguet Thibault13,Schlueter Thorsten14,Schumacher Vanessa15ORCID,Spehar Richard3,Varady William9ORCID,Zeugin Christian1

Affiliation:

1. Novartis Pharma, Basel, Switzerland

2. AbbVie, North Chicago, Illinois, USA

3. Janssen Pharmaceuticals, Beerse, Belgium

4. Charles River Laboratories, Lyon, France

5. Labcorp Early Development Laboratories, Harrogate, UK

6. Merck & Co., Inc., Rahway, New Jersey, USA

7. AbbVie, Ludwigshafen, Germany

8. GlaxoSmithKline, Stevenage, UK

9. Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA

10. Sanofi, Montpellier, France

11. BASF SE, Ludwigshafen, Germany

12. Novo Nordisk, Maaloev, Denmark

13. ANSM, Ile-de-France, France

14. Bayer, Berlin, Germany

15. Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland

Abstract

Digital toxicologic histopathology has been broadly adopted in preclinical compound development for informal consultation and peer review. There is now increased interest in implementing the technology for good laboratory practice–regulated study evaluations. However, the implementation is not straightforward because systems and work processes require qualification and validation, with consideration also given to security. As a result of the high-throughput, high-volume nature of safety evaluations, computer performance, ergonomics, efficiency, and integration with laboratory information management systems are further key considerations. The European Society of Toxicologic Pathology organized an international expert workshop with participation by toxicologic pathologists, quality assurance/regulatory experts, and information technology experts to discuss qualification and validation of digital histopathology systems in a good laboratory practice environment, and to share the resulting conclusions broadly in the toxicologic pathology community.

Publisher

SAGE Publications

Subject

Cell Biology,Toxicology,Molecular Biology,Pathology and Forensic Medicine

Reference27 articles.

1. The Application, Challenges, and Advancement Toward Regulatory Acceptance of Digital Toxicologic Pathology: Results of the 7th ESTP International Expert Workshop (September 20-21, 2019)

2. US Food & Drug Administration. Guidance for industry “technical performance assessment of digital pathology whole slide imaging devices.” Published 2016. Accessed June 19, 2021. https://www.federalregister.gov/documents/2016/04/20/2016-09140/technical-performance-assessment-of-digital-pathology-whole-slide-imaging-devices-guidance-for.

3. Society of Toxicologic Pathology Position Paper on Pathology Image Data: Compliance with 21 CFR Parts 58 and 11

4. Utilizing Whole Slide Images for the Primary Evaluation and Peer Review of a GLP-Compliant Rodent Toxicology Study

5. US Food & Drug Administration. 510(k) substantial equivalence determination decision summary (510(k) number, K201005). Date unknown. Accessed June 29, 2021. https://www.accessdata.fda.gov/cdrh_docs/reviews/K201005.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3